Because Knetbooks knows college students. Our rental program is designed to save you time and money. Whether you need a textbook for a semester, quarter or even a summer session, we have an option for you. Simply select a rental period, enter your information and your book will be on its way!
| Preface | p. xiii |
| Introduction: An Overview of AIDS | p. 1 |
| AIDS in Brief | p. 1 |
| The AIDS Epidemic | p. 2 |
| Concepts of Infectious Disease and a History of Epidemics | p. 5 |
| Factors That Affect the Spread of Epidemics | p. 6 |
| Host and Virus Populations | p. 6 |
| The Transmission Rate | p. 7 |
| Population Densities and Infections | p. 8 |
| C... MORE | p. 9 |
| Controlling Infectious Diseases | p. 10 |
| A History of Epidemics | p. 11 |
| The Old World | p. 11 |
| The New World | p. 12 |
| Modern Concepts of Infectious Disease and Koch's Postulates | p. 13 |
| Epidemics in Modern Times | p. 14 |
| Syphilis: The Social Problems with a Sexually Transmitted Disease | p. 15 |
| The Immune System | p. 17 |
| Blood | p. 17 |
| Cells of the Blood | p. 20 |
| The Lymphatic Circulation | p. 24 |
| B-Cells and Humoral Immunity: The Generation of Antibodies | p. 26 |
| Antibodies | p. 26 |
| How Does the Immune System Respond to New Antigens? | p. 27 |
| Vaccines | p. 33 |
| Tolerance | p. 33 |
| A Summary of the Humoral Immune System | p. 33 |
| T-Cells and Cell-Mediated Immunity | p. 34 |
| Tkiller Lymphocytes | p. 34 |
| Thelper Lymphocytes | p. 36 |
| T-Lymphocyte Recognition of Antigen-Containing Cells | p. 38 |
| Virology and HIV | p. 41 |
| A General Introduction to Viruses | p. 41 |
| What Are Viruses? | p. 42 |
| How Does a Virus Infect a Host? | p. 43 |
| A Typical Virus Infection Cycle | p. 45 |
| How Do We Treat Viral Infections? | p. 47 |
| The Life Cycle of a Retrovirus | p. 48 |
| The AIDS Virus: HIV | p. 51 |
| Features of HIV | p. 52 |
| The Effects of HIV Infection in Individuals | p. 55 |
| The HIV Antibody Test | p. 58 |
| Potential Problems with the HIV Antibody Test | p. 60 |
| Testing for the Level of Circulating HIV | p. 61 |
| How Does HIV Evade the Immune System? | p. 61 |
| Azidothymidine (AZT): The First Effective Drug Treatment in HIV/AIDS | p. 62 |
| Limitations of AZT | p. 63 |
| Protease Inhibitors: Another Class of Drugs Against HIV | p. 64 |
| Where Did HIV Come From? | p. 66 |
| Clinical Manifestations and Treatment of AIDS | p. 67 |
| Exposure, Infection, and Disease | p. 68 |
| Exposure Versus Infection | p. 68 |
| Infection Versus Disease | p. 69 |
| HIV Infection in Untreated Individuals | p. 69 |
| Primary Infection and the Asymptomatic Period | p. 69 |
| Initial Disease Symptoms | p. 72 |
| Damage to the Immune System and Full-Blown AIDS | p. 74 |
| High Turnover of Thelper Cells in AIDS Patients | p. 86 |
| Antiviral Drugs for HIV | p. 87 |
| Reverse Transcriptase Inhibitors | p. 87 |
| Protease Inhibitors | p. 90 |
| Integrase Inhibitors | p. 90 |
| Fusion Inhibitors | p. 90 |
| Clinical Management of HIV-infected Individuals | p. 91 |
| Monitoring Infection and Disease | p. 91 |
| Antiretroviral Therapy | p. 92 |
| Limitations and Uncertainties in ART Therapies | p. 93 |
| Timing the Initiation of ART | p. 95 |
| Prophylaxis for Opportunistic Infections | p. 96 |
| Epidemiology and AIDS | p. 97 |
| An Overview of Epidemiology and AIDS | p. 98 |
| Basic Concepts in Epidemiology | p. 99 |
| Descriptive Studies | p. 100 |
| Analytical Studies | p. 102 |
| Correlations | p. 103 |
| Criteria for a Causal Relationship | p. 104 |
| Epidemiology and AIDS in the United States | p. 105 |
| The Current Picture of AIDS in the United States | p. 105 |
| Epidemiology and Modes of HIV Transmission | p. 108 |
| Likelihood of Progression to AIDS | p. 111 |
| The Effectiveness of AZT | p. 111 |
| The Changing Face of AIDS | p. 112 |
| AIDS Around the World | p. 114 |
| AIDS in Africa | p. 115 |
| AIDS in Asia | p. 118 |
| New Areas of Rapid Spread | p. 119 |
| HIV Subgroups and Clades | p. 119 |
| Modes of HIV Transmission and Personal Risk Factors | p. 121 |
| Biological Bases of HIV Transmission | p. 122 |
| Sources of Infectious HIV | p. 123 |
| Stability of HIV | p. 124 |
| Targets for HIV Infection | p. 124 |
| Modes of HIV Transmission | p. 125 |
| Activities Not Associated with HIV Transmission: Casual Contact | p. 125 |
| Activities Associated with HIV Transmission: Birth, Blood, and Sex | p. 126 |
| Individual Assessments of HIV Risk | p. 135 |
| Introduction to Individual Decision Making and Action | p. 135 |
| Risk Assessment | p. 136 |
| Normative Model | p. 138 |
| Subjective Probability Model | p. 139 |
| HIV Testing and Risk Assessment | p. 147 |
| Nature and Accuracy of the HIV Test | p. 147 |
| Testing Context: HIV Counseling as Part of the HIV Test | p. 149 |
| Testing Options | p. 150 |
| Prevention of AIDS | p. 153 |
| Disease Prevention and Health Promotion | p. 154 |
| Models of Health Behavior Change | p. 154 |
| Health Belief Model | p. 154 |
| Health Decision Model | p. 156 |
| Precaution-Adoption Process Model | p. 156 |
| Principles of Health Behavior Change | p. 157 |
| The Cognitive Principle | p. 158 |
| The Emotional Principle | p. 158 |
| The Behavioral Principle | p. 159 |
| The Interpersonal Principle | p. 159 |
| The Social Ecological Principle | p. 160 |
| The Structural Principle | p. 161 |
| The Scientific Principle | p. 162 |
| Examples of HIV/AIDS Prevention Programs | p. 163 |
| AIDS Prevention Among Young Gay and Bisexual Men | p. 163 |
| AIDS Prevention Among Mexican Migrant Farm Workers | p. 165 |
| Living with AIDS: Human Dimensions | p. 171 |
| Theoretical Perspectives from Social Psychology | p. 172 |
| Role Theories | p. 172 |
| Cognitive Theories | p. 174 |
| Human Dimensions of HIV/AIDS | p. 177 |
| Confronting the News of Infection | p. 177 |
| Accepting the Reality of Infection | p. 180 |
| Opportunities and Challenges of Drug Therapies | p. 186 |
| Living with AIDS: Societal Dimensions | p. 189 |
| Theoretical Concepts | p. 190 |
| Prejudice | p. 190 |
| Discrimination | p. 192 |
| Societal Dimensions of HIV/AIDS | p. 194 |
| Needle Exchange for Injection Drug Users | p. 194 |
| HIV Prevention for Teens | p. 196 |
| Healthcare Practices | p. 197 |
| Future Directions in Combating AIDS | p. 201 |
| Future Directions for Biomedical Efforts | p. 201 |
| Prevention of Infection | p. 201 |
| Treatment of Infected Individuals | p. 205 |
| Future Directions for Social Efforts | p. 211 |
| Education | p. 211 |
| Research | p. 213 |
| A Final Note of Optimism: Time Is on Our Side | p. 214 |
| Glossary | p. 219 |
| Appendix: Reference Resources | p. 229 |
| Index | p. 231 |
| Table of Contents provided by Ingram. All Rights Reserved. |